• Chigutsa, E., Patel, K., Denti, P., Visser, M., Maartens, G., Kirkpatrick, C. M. J., McIlleron, H., & Karlsson, M. O. (2013). A time-to-event pharmacodynamic model describing treatment response in patients with pulmonary tuberculosis using days to positivity in automated liquid mycobacterial culture. Antimicrobial Agents and Chemotherapy57(2), 789–795. https://doi.org/10.1128/AAC.01876-12
     
  • Zhang, C., Denti, P., Decloedt, E. H., Ren, Y., Karlsson, M. O., & McIlleron, H. (2013). Model-based evaluation of the pharmacokinetic differences between adults and children for lopinavir and ritonavir in combination with rifampicin. British Journal of Clinical Pharmacologyhttps://doi.org/10.1111/bcp.12101
     
  • Decloedt, E. H., Mwansa-Kambafwile, J., Van Der Walt, J. S., McIlleron, H., Denti, P., Smith, P., Wiesner, L., Rangaka, M., Wilkinson, R. J., & Maartens, G. (2013). The pharmacokinetics of nevirapine when given with isoniazid in South African HIV-infected individuals. International Journal of Tuberculosis and Lung Disease17(3), 333–335. https://doi.org/10.5588/ijtld.12.0427
     
  • Pillai, G., Davies, G., Denti, P., Steimer, J., McIlleron, H., Zvada, S., Chigutsa, E., Ngaimisi, E., Mirza, F., Tadmor, B., & Holford, N. H. G. (2013). Pharmacometrics: Opportunity for Reducing Disease Burden in the Developing World: The Case of Africa. CPT: Pharmacometrics & Systems Pharmacology2(8), e69. https://doi.org/10.1038/psp.2013.45